查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1493411

實驗室產品和服務外包市場規模、佔有率和趨勢分析報告：按產品類型、技術、最終用途、地區和細分市場預測，2024-2030 年

Laboratory Products And Services Outsourcing Market Size, Share & Trends Analysis Report By Type (Products, Services), By Technology (Molecular Diagnostics, Immunoassays), By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 250 Pages | 商品交期: 2-10個工作天內

價格

實驗室產品和服務外包市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2030年全球實驗室產品和服務外包市場規模將達到671.2億美元，2024年至2030年複合年成長率為8.21%。

臨床試驗數量的增加、個人化醫療和新型療法的採用增加、醫療保健行業研發投資的增加以及醫療設備的技術進步預計將對市場產生積極影響。

截至2023年5月17日，註冊臨床試驗數量已達452,604個，還有64,838個正在積極招募參與企業市場。與 2021 年初報告的超過 365,000 項臨床試驗相比，這一顯著成長代表了臨床研究空間的快速擴張。隨著越來越多的臨床試驗開始，對支持研究各個方面（包括樣本分析、測試和資料管理）的實驗室產品和服務的需求不斷增加。這種不斷成長的需求為外包公司提供了一個利潤豐厚的機會，可以提供專業知識、先進技術和高效的解決方案，以滿足臨床試驗不斷變化的要求，從而推動市場成長。

醫療技術在市場中的整合是擴大醫療保健服務領域的潛在成長動力。醫療技術涵蓋廣泛的設備、軟體和服務，在改善診斷、治療和疾病預防方面發揮著至關重要的作用。利用診斷影像系統（MRI、 電腦斷層掃描）、治療設備（心律調節器、人工關節）和診斷工具（血糖儀）等先進醫療設備，外包公司可以利用專業知識和創新解決方案來滿足不斷變化的需求。醫療保健業。此外，電子健康記錄和遠端醫療平台等醫療保健軟體和服務可以實現更有效率、更有效的護理服務，進一步推動市場成長軌跡。

個人化醫療和新型治療方法的日益普及，特別是精準腫瘤學中基於人工智慧的個人化藥物和細胞療法，凸顯了對現代法規結構的需求。例如，到 2023 年 1 月，這些框架將確保創新方法安全有效地融入醫療保健系統。這篇演講強調了臨床試驗中分散化的好處，強調了透過在更接近患者群體的情況下進行臨床試驗來簡化流程、降低成本和加強患者招募的潛力。此外，以患者為中心的原則已成為個人化醫療發展的基本方面，特別是在精準腫瘤學領域，強調了在醫療決策中優先考慮患者需求、偏好和價值觀的重要性。然而，維持分散臨床試驗的品質和安全性、管理個人化醫療的複雜性以及解決資料隱私和安全問題等挑戰包括適應市場內不斷變化的個人化醫療格局，這需要監管機構提供創新的解決方案。

此外，醫療設備的技術進步是關鍵的成長動力，並將在未來幾年產生重大影響。例如，使用 3D 列印技術自訂植入、矯正器具和燒燙傷患者的皮膚細胞將增強個人化醫療設備的製造並改善患者的治療效果。此外，使用 3D 列印開發人造器官有可能徹底改變器官移植並減少對捐贈器官的依賴。此外，無氦移動 MRI 系統等創新技術擴大了患者獲得診斷掃描的機會，同時解決了環境問題。此外，人工智慧和巨量資料在醫療技術行業的整合，包括在診斷和診斷成像市場的應用，有望帶來變革性的好處，將提高業務效率並推動實驗室產品和服務外包行業的成長機會。

實驗室產品和服務外包市場報告亮點

  • 按產品類型分類，該產品細分市場處於領先地位，2023年將佔全球銷售佔有率的62.2%。對先進和專業設備的高需求推動了設備外包科學研究的進步推動了對準確、高效的實驗室業務的需求，從而推動了對通用、分析、臨床、支援和專業設備的需求不斷增加。
  • 從技術角度來看，分子診斷領域預計將在 2023 年佔據主導地位，並在預測期內以最快的複合年成長率成長。分子生物學技術的進步和個人化醫療方法的採用將進一步推動對分子診斷服務的需求。
  • 按最終用途分類，製藥和生物技術公司預計在預測期內將以 8.4% 的複合年成長率成長最快。由於製藥和生物技術公司對研發、外包趨勢以及對專業知識的需求的關注，它們正在推動實驗室產品和服務外包的成長。
  • 2023 年，北美市場佔據主導地位，佔有率為 38.0%。技術進步、更嚴格的監管要求以及對專業服務的需求增加等因素促成了這一積極的前景。此外，大型製藥企業的存在及其對研發的關注進一步支持了市場擴張。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章實驗室產品與服務外包市場變數、趨勢與範圍

  • 市場體系展望
  • 市場動態
  • 技術進步
  • 定價模式分析
  • 臨床試驗數量分析（2021-2023）
  • 按主要治療領域分類的臨床試驗總數（2021-2023）
  • 實驗室產品與服務外包市場：分析工具
  • COVID-19 影響分析

第4章實驗室產品與服務外包市場：類型估計與趨勢分析

  • 細分儀表板
  • 全球實驗室產品與服務外包市場波動分析
  • 2018-2030年全球實驗室產品與服務外包市場規模及趨勢分析（按類型）
  • 產品
  • 服務

第5章實驗室產品與服務外包市場：技術評估與趨勢分析

  • 細分儀表板
  • 全球實驗室產品與服務外包市場波動分析
  • 2018-2030年全球實驗室產品及服務外包市場規模及趨勢分析（依技術）
  • 免疫學測試
  • 分子診斷
  • 微生物學
  • 臨床化學
  • 流式細胞技術
  • 質譜
  • 層析法
  • 其他

第6章實驗室產品和服務外包市場：最終用途估計和趨勢分析

  • 細分儀表板
  • 全球實驗室產品與服務外包市場波動分析
  • 2018-2030 年全球實驗室產品與服務外包市場規模及趨勢分析（依最終用途）
  • 製藥和生物技術公司
  • 醫療設備公司
  • CRO 和 CDMO
  • 其他

第7章實驗室產品和服務外包市場：按類型、技術和最終用途進行的區域估計和趨勢分析

  • 區域市場儀表板
  • 全球區域市場概述
  • 2018-2030年市場規模、預測趨勢分析：
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第8章 競爭格局

  • 市場參與企業分類
  • 服務熱圖分析（企業比較分析）
  • 公司簡介
    • Thermo Fisher Scientific
    • Charles River Laboratories
    • Eurofins Scientific
    • Labcorp
    • Quest Diagnostics
    • Parexel International Corporation
    • Agilent Technologies
    • PerkinElmer
    • Bio-Rad Laboratories
    • SGS SA
    • Intertek Group plc
    • WuXi AppTec Co., Ltd.
Product Code: GVR-4-68040-264-5

Laboratory Products And Services Outsourcing Market Growth & Trends:

The global laboratory products and services outsourcing market size is expected to reach USD 67.12 billion by 2030, growing at a CAGR of 8.21% from 2024 to 2030, according to a new report by Grand View Research, Inc. A rising number of clinical trials, increased adoption of the personalized medicine and novel therapeutics, increasing R&D investment in the healthcare industry, technological advancement in the medical equipment are anticipated to positively influence the market.

The surge in registered clinical trials globally, reaching 452,604 as of May 17, 2023, with 64,838 actively recruiting participants, serves as a significant growth driver for the market. This notable increase from over 365,000 trials reported in early 2021 signifies a rapid expansion in the clinical research domain. As more trials are initiated, there is a heightened demand for laboratory products and services to support various aspects of research, including sample analysis, testing, and data management. This escalating need presents lucrative opportunities for outsourcing companies to provide specialized expertise, advanced technologies, and efficient solutions to meet the evolving requirements of clinical trials, thus driving the growth of the market.

The integration of medical technology within the market serves as a potential growth driver, enhancing the landscape of healthcare delivery. Medical technology, encompassing an extensive array of devices, software, and services, plays a pivotal role in improving diagnostics, treatment, and disease prevention. Leveraging advanced medical devices such as imaging systems (MRI, CT scans), therapeutic devices (pacemakers, artificial joints), and diagnostic tools (blood glucose meters), outsourcing companies can provide specialized expertise and innovative solutions to meet the evolving demands of the healthcare industry. Additionally, healthcare software and services, including electronic health records and telemedicine platforms, enable more efficient and effective care delivery, further fueling the growth trajectory of the market.

Increasing adoption of personalized medicine and novel therapeutics, particularly within AI-based personalized drug and cell therapies in precision oncology, highlights the necessity for updated regulatory frameworks. For instance, in January 2023, these frameworks ensure the safe and effective integration of innovative approaches into healthcare systems. Highlighting the benefits of decentralization in clinical trials, the discourse emphasizes its potential to streamline processes, reduce costs, and enhance patient recruitment by conducting trials closer to the patient population. Additionally, the principle of patient centricity emerges as a fundamental aspect of personalized medicine development, emphasizing the importance of prioritizing patients' needs, preferences, and values in healthcare decisions, particularly in precision oncology. However, challenges such as maintaining the quality and safety of decentralized trials, managing the complexities of personalized medicine, and addressing data privacy and security concerns require innovative solutions from regulatory bodies to adapt to the evolving landscape of personalized medicine within the market.

Furthermore, technological advancements in medical equipment present significant growth drivers, poised to make substantial impacts in the upcoming years. For instance, the utilization of 3D printing technology for custom implants, prosthetics, and skin cells for burn victims enhances the production of personalized medical devices, improving patient outcomes. Additionally, the development of artificial organs using 3D printing has the potential to revolutionize organ transplantation, reducing reliance on donor organs. Furthermore, innovations including mobile MRI systems with helium-free operations expand patient access to diagnostic scans while addressing environmental concerns. Moreover, integrating AI and Big Data in the medtech industry, including applications in diagnostics and imaging diagnostics markets, promises transformative benefits, enhancing operational efficiencies and driving growth opportunities in the laboratory products and services outsourcing sector.

Laboratory Products And Services Outsourcing Market Report Highlights:

  • Based on type, the product segment led the market and accounted for 62.2% of global revenue share in 2023. High demand for sophisticated and specialized instruments drives equipment outsourcing. Advancements in scientific research necessitate precise and efficient laboratory operations, fueling the need for general, analytical, clinical, support, and specialty equipment.
  • Based on technology, the molecular diagnostics segment dominated in 2023 and is expected to grow at the fastest CAGR during the forecast period. Advancements in molecular biology techniques and the adoption of personalized medicine approaches further boost the demand for molecular diagnostic services.
  • Based on end-use, the pharmaceutical & biotech companies segment is expected to grow at the fastest CAGR of 8.4% during the forecast period. Pharmaceutical & biotech companies drive growth in lab products and services outsourcing due to R&D focus, outsourcing trends, and demand for specialized expertise.
  • North America dominated the market with a share of 38.0% in 2023. Factors such as technological advancements, stringent regulatory requirements, and the increasing demand for specialized services contribute to this positive outlook. Additionally, the presence of leading pharmaceutical and biotechnology companies and a strong emphasis on research and development further propels market expansion.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Regional Scope
    • 1.1.2. Estimates and Forecast Timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
    • 1.3.5. Details of Primary Research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Validation
    • 1.5.1. Region Wise Market: Base Estimates
    • 1.5.2. Global Market: CAGR Calculation
  • 1.6. Model Details
    • 1.6.1. Commodity Flow Analysis (Model 1)
    • 1.6.2. Value-Chain-Based Sizing & Forecasting (Model 2)
    • 1.6.3. QFD Model Sizing & Forecasting (Model 3)
    • 1.6.4. Bottom-Up Approach (Model 4)
  • 1.7. Market Definitions
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. Objectives
    • 1.10.1. Objective - 1:
    • 1.10.2. Objective - 2:
    • 1.10.3. Objective - 3:
    • 1.10.4. Objective - 4:

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Laboratory Products and Services Outsourcing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing Number of Clinical Trials
      • 3.2.1.2. Increasing Adoption of the Personalized Medicine and Novel Therapeutics
      • 3.2.1.3. Rising R&D Investment in the Healthcare Industry
      • 3.2.1.4. Technological Advancement in the Medical Equipment
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Regulatory Challenges
      • 3.2.2.2. Managing Relationships
  • 3.3. Technological Advancements
  • 3.4. Pricing Model Analysis
  • 3.5. Clinical Trial Volume Analysis (2021 - 2023)
    • 3.5.1. Total Number of Clinical Trials, by Region (2021 - 2023)
    • 3.5.2. Total Number of Clinical Trials, by Phase (2021 - 2023)
    • 3.5.3. Total Number of Clinical Trials, by Study Design (2021 - 2023)
  • 3.6. Total Number of Clinical Trials, by Key Therapeutic Area (2021 - 2023)
  • 3.7. Laboratory Products And Services Outsourcing Market: Analysis Tools
    • 3.7.1. Porter's Five Forces Analysis
    • 3.7.2. PESTEL Analysis
  • 3.8. COVID-19 Impact Analysis

Chapter 4. Laboratory Products and Services Outsourcing Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Laboratory Products and Services Outsourcing Market Movement Analysis
  • 4.3. Global Laboratory Products and Services Outsourcing Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Products
    • 4.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 4.4.2. Equipment
      • 4.4.2.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.4.2.2. General
      • 4.4.2.2.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.4.2.3. Analytical
      • 4.4.2.3.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.4.2.4. Clinical
      • 4.4.2.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.4.2.5. Support
      • 4.4.2.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.4.2.6. Specialty
      • 4.4.2.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 4.4.3. Disposables
      • 4.4.3.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 4.5.2. Pharmaceutical
      • 4.5.2.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.2. Bioanalytical Testing
      • 4.5.2.2.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.2.2. ADME
      • 4.5.2.2.2.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.2.3. PK
      • 4.5.2.2.3.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.2.4. PD
      • 4.5.2.2.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.2.5. Bioavailability
      • 4.5.2.2.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.2.6. Bioequivalence
      • 4.5.2.2.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.2.7. Others
      • 4.5.2.2.7.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.3. Method Development & Validation
      • 4.5.2.3.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.3.2. Extractable & Leachable
      • 4.5.2.3.2.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.3.3. Impurity Method
      • 4.5.2.3.3.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.3.4. Technical Consulting
      • 4.5.2.3.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.3.5. Others
      • 4.5.2.3.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.4. Stability Testing
      • 4.5.2.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.4.2. Drug Substance
      • 4.5.2.4.2.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.4.3. Stability Indicating Method Validation
      • 4.5.2.4.3.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.4.4. Accelerated Stability Testing
      • 4.5.2.4.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.4.5. Photostability Testing
      • 4.5.2.4.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.4.6. Others
      • 4.5.2.4.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.2.5. Others
      • 4.5.2.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 4.5.3. Medical Device
      • 4.5.3.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.3.1.1. Biocompatibility Tests
      • 4.5.3.1.1.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.3.1.2. Chemistry Test
      • 4.5.3.1.2.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.3.1.3. Microbiology & Sterility Testing
      • 4.5.3.1.3.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
      • 4.5.3.1.4. Others
      • 4.5.3.1.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 5. Laboratory Products and Services Outsourcing Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Laboratory Products and Services Outsourcing Market Movement Analysis
  • 5.3. Global Laboratory Products and Services Outsourcing Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 5.4. Immunoassays
    • 5.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.5. Molecular Diagnostics
    • 5.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.6. Microbiology
    • 5.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.7. Clinical Chemistry
    • 5.7.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.8. Flow Cytometry
    • 5.8.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.9. Mass Spectroscopy
    • 5.9.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.10. Chromatography
    • 5.10.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 5.11. Others
    • 5.11.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 6. Laboratory Products and Services Outsourcing Market: End-use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Laboratory Products and Services Outsourcing Market Movement Analysis
  • 6.3. Global Laboratory Products and Services Outsourcing Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotech Companies
    • 6.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 6.5. Medical Device Companies
    • 6.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 6.6. CRO & CDMO
    • 6.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 7. Laboratory Products and Services Outsourcing Market: Regional Estimates & Trend Analysis by Type, Technology & End-use

  • 7.1. Regional Market Dashboard
  • 7.2. Global Regional Market Snapshot
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Scenario
      • 7.4.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Scenario
      • 7.4.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Scenario
      • 7.5.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Scenario
      • 7.5.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Scenario
      • 7.5.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Scenario
      • 7.5.5.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Scenario
      • 7.5.6.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.7. Denmark
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Scenario
      • 7.5.7.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Scenario
      • 7.5.8.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.5.9. Norway
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Scenario
      • 7.5.9.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Scenario
      • 7.6.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.3. Japan
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Scenario
      • 7.6.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Scenario
      • 7.6.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Scenario
      • 7.6.5.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Scenario
      • 7.6.6.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Scenario
      • 7.6.7.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Scenario
      • 7.7.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.7.3. Mexico
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Scenario
      • 7.7.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.7.4. Argentina
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Scenario
      • 7.7.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Scenario
      • 7.8.2.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Scenario
      • 7.8.3.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Scenario
      • 7.8.4.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Scenario
      • 7.8.5.4. Market Estimates and Forecast, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Service Heat Map Analysis (a comparative analysis of the players together)
  • 8.3. Company Profiles
    • 8.3.1. Thermo Fisher Scientific
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Product/Service Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Charles River Laboratories
      • 8.3.2.1. Company Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Product/Service Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Eurofins Scientific
      • 8.3.3.1. Company Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Product/Service Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. Labcorp
      • 8.3.4.1. Company Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Product/Service Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Quest Diagnostics
      • 8.3.5.1. Company Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Product/Service Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Parexel International Corporation
      • 8.3.6.1. Company Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Product/Service Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Agilent Technologies
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Product/Service Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. PerkinElmer
      • 8.3.8.1. Company Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Product/Service Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Bio-Rad Laboratories
      • 8.3.9.1. Company Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Product/Service Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. SGS SA
      • 8.3.10.1. Company Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Product/Service Benchmarking
      • 8.3.10.4. Strategic Initiatives
    • 8.3.11. Intertek Group plc
      • 8.3.11.1. Company Overview
      • 8.3.11.2. Financial Performance
      • 8.3.11.3. Product/Service Benchmarking
      • 8.3.11.4. Strategic Initiatives
    • 8.3.12. WuXi AppTec Co., Ltd.
      • 8.3.12.1. Company Overview
      • 8.3.12.2. Financial Performance
      • 8.3.12.3. Product/Service Benchmarking
      • 8.3.12.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 4 Global Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 5 Global Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 6 Global Laboratory Products and Services Outsourcing, by Region, 2018 - 2030 (USD Million)
  • Table 7 North America Laboratory Products and Services Outsourcing, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 9 North America Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 10 North America Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 11 U.S. Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 12 U.S. Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 13 U.S. Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 14 Canada Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 15 Canada Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 16 Canada Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 17 Europe Laboratory Products and Services Outsourcing, by Country, 2018 - 2030 (USD Million)
  • Table 18 Europe Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 19 Europe Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 20 Europe Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 21 Germany Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 22 Germany Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 23 Germany Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 24 UK Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 25 UK Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 26 UK Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 27 France Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 28 France Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 29 France Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 30 Italy Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 31 Italy Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 32 Italy Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 33 Spain Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 34 Spain Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 35 Spain Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 36 Denmark Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 37 Denmark Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 38 Denmark Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 39 Sweden Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 40 Sweden Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 41 Sweden Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 42 Norway Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 43 Norway Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 44 Norway Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Laboratory Products and Services Outsourcing, by Country, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 49 China Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 50 China Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 51 China Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 52 Japan Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 53 Japan Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 54 Japan Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 55 India Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 56 India Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 57 India Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 58 South Korea Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 59 South Korea Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 60 South Korea Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 61 Australia Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 62 Australia Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 63 Australia Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 64 Thailand Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 65 Thailand Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 66 Thailand Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 67 Latin America Laboratory Products and Services Outsourcing, by Country, 2018 - 2030 (USD Million)
  • Table 68 Latin America Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 69 Latin America Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 70 Latin America Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 71 Brazil Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 72 Brazil Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 73 Brazil Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 74 Mexico Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 75 Mexico Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 76 Mexico Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 77 Argentina Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 78 Argentina Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 79 Argentina Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Laboratory Products and Services Outsourcing, by Country, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 83 Middle East & Africa Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 84 South Africa Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 85 South Africa Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 86 South Africa Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 90 UAE Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 91 UAE Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 92 UAE Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Laboratory Products and Services Outsourcing, by Type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Laboratory Products and Services Outsourcing, by Technology, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Laboratory Products and Services Outsourcing, by End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Laboratory Products and Services Outsourcing, Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Regional Marketplace: Key Takeaways
  • Fig. 12 Global Laboratory Products and Services Outsourcing, for Product, 2018 - 2030 (USD Million)
  • Fig. 13 Global Laboratory Products and Services Outsourcing, for Equipment, 2018 - 2030 (USD Million)
  • Fig. 14 Global Laboratory Products and Services Outsourcing, for Equipment, 2018 - 2030 (USD Million)
  • Fig. 15 Global Laboratory Products and Services Outsourcing, for General, 2018 - 2030 (USD Million)
  • Fig. 16 Global Laboratory Products and Services Outsourcing, for Analytical, 2018 - 2030 (USD Million)
  • Fig. 17 Global Laboratory Products and Services Outsourcing, for Clinical, 2018 - 2030 (USD Million)
  • Fig. 18 Global Laboratory Products and Services Outsourcing, for Support, 2018 - 2030 (USD Million)
  • Fig. 19 Global Laboratory Products and Services Outsourcing, for Specialty, 2018 - 2030 (USD Million)
  • Fig. 20 Global Laboratory Products and Services Outsourcing, for Disposables, 2018 - 2030 (USD Million)
  • Fig. 21 Global Laboratory Products and Services Outsourcing, for Others, 2018 - 2030 (USD Million)
  • Fig. 22 Global Laboratory Products and Services Outsourcing, for Services, 2018 - 2030 (USD Million)
  • Fig. 23 Global Laboratory Products and Services Outsourcing, for Pharmaceutical, 2018 - 2030 (USD Million)
  • Fig. 24 Global Laboratory Products and Services Outsourcing, for Bioanalytical Testing, 2018 - 2030 (USD Million)
  • Fig. 25 Global Laboratory Products and Services Outsourcing, for ADME, 2018 - 2030 (USD Million)
  • Fig. 26 Global Laboratory Products and Services Outsourcing, for PK, 2018 - 2030 (USD Million)
  • Fig. 27 Global Laboratory Products and Services Outsourcing, for PD, 2018 - 2030 (USD Million)
  • Fig. 28 Global Laboratory Products and Services Outsourcing, for Bioavailability, 2018 - 2030 (USD Million)
  • Fig. 29 Global Laboratory Products and Services Outsourcing, for Bioequivalence, 2018 - 2030 (USD Million)
  • Fig. 30 Global Laboratory Products and Services Outsourcing, for Others, 2018 - 2030 (USD Million)
  • Fig. 31 Global Laboratory Products and Services Outsourcing, for Method Development and Validation, 2018 - 2030 (USD Million)
  • Fig. 32 Global Laboratory Products and Services Outsourcing, for Extractable and Leachable, 2018 - 2030 (USD Million)
  • Fig. 33 Global Laboratory Products and Services Outsourcing, for Impurity Method, 2018 - 2030 (USD Million)
  • Fig. 34 Global Laboratory Products and Services Outsourcing, for Technical Consulting, 2018 - 2030 (USD Million)
  • Fig. 35 Global Laboratory Products and Services Outsourcing, for Others, 2018 - 2030 (USD Million)
  • Fig. 36 Global Laboratory Products and Services Outsourcing, for Stability Testing, 2018 - 2030 (USD Million)
  • Fig. 37 Global Laboratory Products and Services Outsourcing, for Drug Substance, 2018 - 2030 (USD Million)
  • Fig. 38 Global Laboratory Products and Services Outsourcing, for Stability Indicating Method Validation, 2018 - 2030 (USD Million)
  • Fig. 39 Global Laboratory Products and Services Outsourcing, for Accelerated Stability Testing, 2018 - 2030 (USD Million)
  • Fig. 40 Global Laboratory Products and Services Outsourcing, for Photostability Testing, 2018 - 2030 (USD Million)
  • Fig. 41 Global Laboratory Products and Services Outsourcing, for Others, 2018 - 2030 (USD Million)
  • Fig. 42 Global Laboratory Products and Services Outsourcing, for Medical Device, 2018 - 2030 (USD Million)
  • Fig. 43 Global Laboratory Products and Services Outsourcing, for Biocompatibility Tests, 2018 - 2030 (USD Million)
  • Fig. 44 Global Laboratory Products and Services Outsourcing, for Chemistry Test, 2018 - 2030 (USD Million)
  • Fig. 45 Global Laboratory Products and Services Outsourcing, for Microbiology & Sterility Testing, 2018 - 2030 (USD Million)
  • Fig. 46 Global Laboratory Products and Services Outsourcing, for Others, 2018 - 2030 (USD Million)
  • Fig. 47 Global Laboratory Products and Services Outsourcing, for Immunoassays, 2018 - 2030 (USD Million)
  • Fig. 48 Global Laboratory Products and Services Outsourcing, for Molecular Diagnostics, 2018 - 2030 (USD Million)
  • Fig. 49 Global Laboratory Products and Services Outsourcing, for Microbiology, 2018 - 2030 (USD Million)
  • Fig. 50 Global Laboratory Products and Services Outsourcing, for Clinical Chemistry, 2018 - 2030 (USD Million)
  • Fig. 51 Global Laboratory Products and Services Outsourcing, for Flow Cytometry, 2018 - 2030 (USD Million)
  • Fig. 52 Global Laboratory Products and Services Outsourcing, for Chromatography, 2018 - 2030 (USD Million)
  • Fig. 53 Global Laboratory Products and Services Outsourcing, for Mass Spectroscopy, 2018 - 2030 (USD Million)
  • Fig. 54 Global Laboratory Products and Services Outsourcing, for Others, 2018 - 2030 (USD Million)
  • Fig. 55 Global Laboratory Products and Services Outsourcing, for Medical Device Companies, 2018 - 2030 (USD Million)
  • Fig. 56 Global Laboratory Products and Services Outsourcing, for Pharmaceutical & Biotech Companies, 2018 - 2030 (USD Million)
  • Fig. 57 Global Laboratory Products and Services Outsourcing, for CRO & CDMO, 2018 - 2030 (USD Million)
  • Fig. 58 Global Laboratory Products and Services Outsourcing, for Others, 2018 - 2030 (USD Million)
  • Fig. 59 Regional Outlook, 2023 & 2030
  • Fig. 60 North America Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 U.S. Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Canada Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Europe Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Germany Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 UK Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 France Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Italy Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Spain Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Denmark Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Sweden Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Norway Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Asia Pacific Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Japan Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 China Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 India Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Australia Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 South Korea Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Thailand Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Latin America Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Brazil Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Mexico Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Argentina Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Middle East and Africa Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 South Africa Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Saudi Arabia Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 UAE Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Kuwait Laboratory Products and Services Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)